Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP SUSQUEHANNA INTERNATIONAL GROUP, LLP

GALTGALT
Showing 8 of 31 quarters

Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLPSUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in GALECTIN THERAPEUTICS INC

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds 177,197 shares of GALT (GALECTIN THERAPEUTICS INC), worth $822,194 as of 2026-Q2. The position was decreased (-68.1% shares). GALT represents 0.0% of SUSQUEHANNA INTERNATIONAL GROUP, LLP's portfolio.

Current Value

$822,194

Current Shares

177,197

Total Value Change

+$598,160

Total Shares Change

+95,730

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
177,197
-68.1%
$822,1940.0%$4.64
0
2026-Q1
Increased
555,702
+93.7%
$1.6M0.0%$2.98
41
2025-Q4
Decreased
286,919
-35.8%
$1.2M0.0%$4.08
0
2025-Q3
Increased
446,578
+131.2%
$1.9M0.0%$4.22
42
2025-Q2
Increased
193,200
+1603.0%
$407,6520.0%$2.33
38
2025-Q1
Increased
11,345
+10.7%
$13,8410.0%$1.52
13
2024-Q4
Decreased
10,253
-87.4%
$13,2260.0%$1.10
0
2024-Q3
Decreased
81,467
-59.7%
$224,0340.0%$2.71
0

Other major holders of GALT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, OSAIC HOLDINGS, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used